Pfizer Ends COVID-19 Trial With 95% Efficacy, To Seek Emergency-Use Authorization
1 sourceUpdated Nov 18, 2020
Pfizer Inc <PFE.N> said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Sponsored
Coverage
Comments
Ask Genius by OpenServe:
Free account · your comment posts right after signup
Sponsored